Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | L3MBTL3 | Q96JM7 | 4/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | AGTR2 | P50052 | 9/20 | 0.44 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.44 |
| ▸ | TP53BP1 | Q12888 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31482130 | 0.81 | ADRA1A (0.56) | L3MBTL3L3MBTL1 | |
| Hydrochloric Acid SCHEMBL31482115 | 0.81 | ADRA1A (0.55) | L3MBTL3L3MBTL1 | |
| SCHEMBL31482182 | 0.77 | ADRA1A (0.49) | L3MBTL3L3MBTL1 | |
| SCHEMBL31482148 | 0.76 | PROKR1 (0.38) | NPC1MAPTRAB9ASMN1; SMN2L3MBTL3 | |
| SCHEMBL31482120 | 0.76 | L3MBTL3 (0.44) | L3MBTL3L3MBTL1 | |
| SCHEMBL31482152 | 0.76 | ADRA1A (0.60) | L3MBTL3L3MBTL1 | |
| SCHEMBL31482196 | 0.75 | ADRA1A (0.57) | L3MBTL3L3MBTL1 | |
| SCHEMBL31482146 | 0.75 | ADRA2C (0.51) | L3MBTL3L3MBTL1 | |
| SCHEMBL1659661 | 0.71 | L3MBTL3 (0.41) | NPC1RAB9AL3MBTL3L3MBTL1 | |
| SCHEMBL1658448 | 0.71 | HPGD (0.57) | NPC1MAPTRAB9AL3MBTL3L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025068514-A1 | SUBSTITUTED HETEROCYCLIC CARBOXAMINDES AND USE THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 2025-04-03 | — | — | WO | disclosed |